Great announcement and the switch to targeting cancer pain where we know fetanyl derived products have dominated is a good move. Alot of them have been pulled from shelves which will leave a big gap in the market in the coming years which gives inhalerx a chance to fill the void......
IND submission is overdue and should be lodged any day now!!!
Great announcement and the switch to targeting cancer pain where...
Add IRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.933M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 95708 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 184000 | 1 |
View Market Depth
| Last trade - 10.04am 11/07/2024 (20 minute delay) ? |
| IRX (ASX) Chart |
Day chart unavailable